Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Axogen Inc (NQ: AXGN ) 14.37 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Sep 24, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 14.37 Bid (Size) 5.750 (2) Ask (Size) 16.41 (4) Prev. Close 14.37 Today's Range 14.37 - 14.37 52wk Range 3.450 - 15.08 Shares Outstanding 41,397,053 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft® September 06, 2024 From Axogen, Inc. Via GlobeNewswire Axogen Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(C)(4) September 03, 2024 From Axogen, Inc. Via GlobeNewswire Performance YTD +107.96% +107.96% 1 Month +13.51% +13.51% 3 Month +97.39% +97.39% 6 Month +90.33% +90.33% 1 Year +187.98% +187.98% More News Read More CytoSorbents Appoints Peter J. Mariani Chief Financial Officer August 13, 2024 From CytoSorbents Via GlobeNewswire Axogen Earnings Preview March 04, 2024 Via Benzinga AXGN Stock Earnings: Axogen Beats EPS, Beats Revenue for Q2 2024 August 08, 2024 Via InvestorPlace Parker-Hannifin Posts Upbeat Earnings, Joins Under Armour, Zillow Group, YETI Holdings, Eli Lilly And Other Big Stocks Moving Higher On Thursday August 08, 2024 Via Benzinga Axogen, Inc. Announces New Leadership Appointments August 08, 2024 From Axogen, Inc. Via GlobeNewswire Axogen, Inc. Reports Second Quarter 2024 Financial Results August 08, 2024 From Axogen, Inc. Via GlobeNewswire Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024 July 23, 2024 From Axogen, Inc. Via GlobeNewswire Company Reports Inducement Grants to Non-Executive New Employee Under Nasdaq Listing Rule 5635(C)(4) July 01, 2024 From Axogen, Inc. Via GlobeNewswire Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™ June 24, 2024 From Axogen, Inc. Via GlobeNewswire Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia May 28, 2024 From Axogen, Inc. Via GlobeNewswire Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft® May 16, 2024 From Axogen, Inc. Via GlobeNewswire Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads Conference May 14, 2024 From Axogen, Inc. Via GlobeNewswire AXGN Stock Earnings: Axogen Beats EPS, Misses Revenue for Q1 2024 May 02, 2024 Via InvestorPlace Axogen, Inc Reports First Quarter 2024 Financial Results May 02, 2024 From Axogen, Inc. Via GlobeNewswire Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™ April 29, 2024 From Axogen, Inc. Via GlobeNewswire Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024 April 16, 2024 From Axogen, Inc. Via GlobeNewswire Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session March 05, 2024 Via Benzinga AXGN Stock Earnings: Axogen Beats EPS, Beats Revenue for Q4 2023 March 05, 2024 Via InvestorPlace Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results March 05, 2024 From Axogen, Inc. Via GlobeNewswire Earnings Scheduled For March 5, 2024 March 05, 2024 Via Benzinga Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024 February 13, 2024 From Axogen, Inc. Via GlobeNewswire Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) February 02, 2024 From Axogen, Inc. Via GlobeNewswire Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap January 18, 2024 From Axogen, Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
